BioPharm International
January 01, 2012
Compliance Notes
25
1
Contract organizations must have highly organized teams and plans to accommodate today's audits.
January 01, 2012
From the Editor
25
1
The benefits of harmonization may be on industry's wish list, but buying into change is another story.
January 01, 2012
Final Word
25
1
Government plans require investment, partnership, and industry collaboration.
January 01, 2012
Features
25
1
Recombinant technology can be used to produce conjugate vaccines.
January 01, 2012
Features
25
1
Has an approval in oncology reignited interest in the recruitment of the immune system in the fight against disease?
January 01, 2012
Regulatory Beat
25
1
Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
January 01, 2012
Features
25
1
This month, we rewind to "Separations Technology Outlook, Part II: Improved Recovery and Greater Purity."
January 01, 2012
Features
25
1
Approaches for risk assessment of extractables and leachables.
January 01, 2012
Burrill on Biotech
25
1
Greater emphasis on focus and efficiency for companies as market demands value in 2012.
January 01, 2012
Features
25
1
The authors describe a novel means to control ice nucleation using a sterile cryogenic ice fog.
January 01, 2012
Perspectives on Outsourcing
25
1
Some recent private-equity buyouts of CROs show both the upside and downside for investors.